- Home
- AEON vs HHS Comparison
AEON vs HHS Comparison
Compare AEON & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.04
HOLD
Current Price
$2.91
Company Overview
Basic Information| Metric | AEON | HHS |
|---|---|---|
| Founded | N/A | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.2M | 22.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AEON | HHS |
|---|---|---|
| Price | $1.04 | $2.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 236.3K | 6.2K |
| Earning Date | 03-23-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $166,841,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.38 | $2.33 |
| 52 Week High | $10.01 | $5.54 |
Technical Indicators
Market Signals| Indicator | AEON | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | 40.42 |
| Support Level | $1.01 | $2.91 |
| Resistance Level | $1.13 | $3.18 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 7.69 | 0.03 |
Price Performance
Historical Comparison AEON
HHS
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.